This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Manfred Boehm: Innovator in iPSC-Derived Cell Technologies
Introduction
Manfred Boehm is a distinguished inventor based in Bethesda, MD (US). He has made significant contributions to the field of regenerative medicine and cell therapy, holding a total of 3 patents. His work focuses on the development of innovative cell lines that can be utilized for therapeutic applications and drug screenings.
Latest Patents
One of his latest patents is titled "Human iPSC-derived vascular-related and hematopoietic cells for therapies and toxicology/drug screenings." This patent describes cells, cell culture methods, and media compositions that are instrumental in producing and maintaining induced pluripotent stem cell (iPSC)-derived cell lines. These cell lines exhibit higher purity and better integrity compared to existing iPSC-derived lines. The patent also outlines methods for utilizing these cells in therapeutic applications. The cells include iPSC-derived mesodermal precursor cells (MPC), which can differentiate into various cell types, such as hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), smooth muscle cells (SMC), and unlimited functional endothelial cells (UFEC). A notable feature of these cells is their ability to be maintained in culture for extended periods without undergoing phenotypic changes.
Career Highlights
Manfred Boehm is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to advance his research in cell technologies and contribute to the scientific community.
Collaborations
Throughout his career, Manfred has collaborated with notable colleagues, including Guibin Chen and Mahendra Rao. These collaborations have further enriched his research and innovation in the field of cell therapy.
Conclusion
Manfred Boehm's contributions to the development of iPSC-derived cell technologies have the potential to revolutionize therapeutic approaches in medicine. His innovative patents and ongoing research continue to pave the way for advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile